The Treatment of Cases of Ascariasis with Piperazine Citrate

With Observations of the Effect of the Drug on Other Helminthiases

Clyde Swartzwelder Departments of Microbiology, Public Health and Pediatrics, Louisiana State University School of Medicine and the Charity Hospital of Louisiana, New Orleans, La.

Search for other papers by Clyde Swartzwelder in
Current site
Google Scholar
PubMed Close
,
Joseph H. Miller Departments of Microbiology, Public Health and Pediatrics, Louisiana State University School of Medicine and the Charity Hospital of Louisiana, New Orleans, La.

Search for other papers by Joseph H. Miller in
Current site
Google Scholar
PubMed Close
, and
Robert W. Sappenfield Departments of Microbiology, Public Health and Pediatrics, Louisiana State University School of Medicine and the Charity Hospital of Louisiana, New Orleans, La.

Search for other papers by Robert W. Sappenfield in
Current site
Google Scholar
PubMed Close
DOI:
https://doi.org/10.4269/ajtmh.1955.4.326
Volume/Issue:
Volume 4: Issue 2
Page(s):
326–331
Restricted access
Get Permissions

Summary

The efficacy of piperazine citrate (Antepar) for the elimination of light and heavy infections with Ascaris lumbricoides over a wide range of dosage was demonstrated. No evidence of intolerance of the drug was observed in children during therapy with high dosage.

Author Notes

Published Online:
Mar 1955
Cover The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
Print ISSN:
0002-9637

Expert Committee on Hepatitis

First Report. World Health Organization Technical Report Series No. 62 (Available also in French). 26 pp. Geneva, W.H.O., Palais des Nations. March, 1953. Price 1/6, $0.20, Fr. fr. 65.-; Sw. fr. 0.80

Past two years Past Year Past 30 Days
Abstract Views 1495 1218 295
Full Text Views 12 1 0
PDF Downloads 11 2 0
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save